{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:38Z","timestamp":1786119098702,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Myeloid\/lymphoid neoplasms with eosinophilia (MLN-eos) are rare hematological malignancies in childhood and limited to isolated case reports in the literature. We discuss the case of an infant who was evaluated for persistent hypereosinophilia and diagnosed with a rare genetic rearrangement; GOLGA4::PDGFRB was previously reported only once in a 13-month-old boy. A literature review of all children with PDGFRB rearrangement was collated in our analysis. The challenges of diagnosis, treatment, and follow-up posed by such a rare genetic disorder with no pediatric guidelines are being discussed.<\/jats:p>","DOI":"10.1097\/mph.0000000000003189","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:00:10Z","timestamp":1774645210000},"page":"173-177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Myeloproliferative Neoplasm With Eosinophilia Exhibiting a Rare GOLGA4-PDGFRB Rearrangement in an Infant: Navigating a Rare Malignancy Amidst Limited Pediatric Guidelines"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-3382","authenticated-orcid":false,"given":"Yamini","family":"Krishnan","sequence":"first","affiliation":[{"name":"Department of Paediatric Haematology Oncology and Bone Marrow Transplantation, MVR Cancer Centre and Research Institute, Kozhikode, Kerala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Bhaskaran","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology and Bone Marrow Transplantation, MVR Cancer Centre and Research Institute, Kozhikode, Kerala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazel","family":"Sainulabdin","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology and Bone Marrow Transplantation, MVR Cancer Centre and Research Institute, Kozhikode, Kerala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Vettakorumakankavu Parameswaran","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology and Bone Marrow Transplantation, MVR Cancer Centre and Research Institute, Kozhikode, Kerala"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Mohanty","sequence":"additional","affiliation":[{"name":"HCG Centre for Biorepository and Biobanking and Biomarker Discovery, Health Care Global Cancer Centre (HCG), Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"R1-20260423","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ijlh.12057","article-title":"Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review","volume":"35","author":"Savage","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"R2-20260423","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali","year":"2024","journal-title":"Am J Hematol"},{"key":"R3-20260423","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood-2003-06-1824","article-title":"The FIP1L1-PDGFR\u03b1 fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management","volume":"103","author":"Gotlib","year":"2004","journal-title":"Blood"},{"key":"R4-20260423","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.critrevonc.2016.11.008","article-title":"Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies","volume":"109","author":"Appiah-Kubi","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"R5-20260423","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood-2014-02-555607","article-title":"Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib","volume":"123","author":"Cheah","year":"2014","journal-title":"Blood"},{"key":"R6-20260423","doi-asserted-by":"crossref","first-page":"p.909A","DOI":"10.1182\/blood.V106.11.3253.3253","article-title":"The platelet-derived growth factor receptor beta fuses to two distinct loci at 3p21 in imatinib responsive chronic eosinophilic leukemia","volume":"106","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"R7-20260423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cancergen.2023.01.002","article-title":"Rare and potentially fatal-cytogenetically cryptic TNIP1:: PDGFRB and PCM1:: FGFR1 fusion leading to myeloid\/lymphoid neoplasms with eosinophilia in children","volume":"272-273","author":"Berking","year":"2023","journal-title":"Cancer Genet"},{"key":"R8-20260423","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-20260423","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2141.2008.07033.x","article-title":"A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients","volume":"141","author":"Helbig","year":"2008","journal-title":"Br J Haematol"},{"key":"R10-20260423","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00277-017-3067-x","article-title":"Imatinib in myeloid\/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase","volume":"96","author":"Jawhar","year":"2017","journal-title":"Ann Hematol"},{"key":"R11-20260423","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2016.250","article-title":"NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors","volume":"31","author":"Byrgazov","year":"2017","journal-title":"Leukemia"},{"key":"R12-20260423","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.2147\/JIR.S427995","article-title":"Myeloid\/Lymphoid neoplasms with ETV6::PDGFRB fusion gene: a rare case of poor response to Imatinib and possible transformation mechanisms from myeloid neoplasms of bone marrow to T-Cell lymphoblastic lymphoma invasion in lymph nodes","volume":"16","author":"Gou","year":"2023","journal-title":"J Inflamm Res"},{"key":"R13-20260423","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/leu.2012.162","article-title":"Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome","volume":"26","author":"Pardanani","year":"2012","journal-title":"Leukemia"},{"key":"R14-20260423","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2010","journal-title":"Lancet Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:20Z","timestamp":1786037420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003189","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"2025-10-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}